Clinigen Group Plc (CLIGF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2021 | 06-2020 | 06-2019 | 06-2017 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 111,575 | 180,421 | 108,909 | N/A | N/A |
| Marketable Securities | N/A | 252 | 2,870 | N/A | N/A |
| Receivables | 219,651 | 158,735 | 143,734 | N/A | N/A |
| Inventories | 76,178 | 54,845 | 46,172 | N/A | N/A |
| TOTAL | $407,404 | $394,252 | $301,685 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 18,304 | 16,895 | 17,739 | N/A | N/A |
| Investments And Advances | 1,481 | 0 | 8,478 | 0 | 0 |
| Intangibles | 966,760 | 993,889 | 1,058,961 | 0 | 0 |
| Other Non-Current Assets | 40,242 | 34,798 | 3,653 | 0 | 0 |
| TOTAL | $1,026,787 | $1,045,581 | $1,088,830 | $N/A | $N/A |
| Total Assets | $1,434,191 | $1,439,834 | $1,390,514 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,460 | 5,421 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 218,036 | 245,730 | 307,424 | 0 | 0 |
| Accrued Expenses | 8,075 | 4,665 | 9,521 | N/A | N/A |
| Other current liabilities | N/A | 378 | 522 | N/A | N/A |
| TOTAL | $232,572 | $256,195 | $317,467 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 557,068 | 568,243 | 438,114 | N/A | N/A |
| Other Non-Current Liabilities | 2,288 | 11,221 | 9,521 | 0 | 0 |
| TOTAL | $600,002 | $621,827 | $501,243 | $N/A | $N/A |
| Total Liabilities | $832,574 | $878,021 | $818,709 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | N/A | 114,601 |
| Common Shares | 135 | 126 | 130 | N/A | N/A |
| Retained earnings | 165,815 | 125,450 | 124,169 | N/A | N/A |
| Other shareholders' equity | 112,383 | 133,393 | 134,213 | 0 | 0 |
| TOTAL | $601,617 | $561,813 | $571,805 | $N/A | $N/A |
| Total Liabilities And Equity | $1,434,191 | $1,439,834 | $1,390,514 | $0 | $0 |